80 related articles for article (PubMed ID: 3545877)
21. High efficiency of a new immunological magnetic cell sorting method for T cell depletion of human bone marrow.
Kögler G; Capdeville AB; Hauch M; Brüster HT; Göbel U; Wernet P; Burdach S
Bone Marrow Transplant; 1990 Sep; 6(3):163-8. PubMed ID: 2252955
[TBL] [Abstract][Full Text] [Related]
22. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
23. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
Ramakrishnan S; Uckun FM; Houston LL
J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
[TBL] [Abstract][Full Text] [Related]
24. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
Woolfrey AE; Neudorf S; Filipovich AH
Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
[TBL] [Abstract][Full Text] [Related]
26. Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.
Greenberger JS; Rothstein L; DeFabritiis P; Bregni M; Bast R; Ritz J; Nadler LM; Lipton JM; Sakakeeny MA
Cancer Res; 1985 Feb; 45(2):758-67. PubMed ID: 3967246
[TBL] [Abstract][Full Text] [Related]
27. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
28. T-cell depletion and haematological side effects of two cytotoxic monoclonal antibodies.
Leiblein S; Schulze E; Pönisch W; Behn I; Fiebig H; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):793-7. PubMed ID: 1713884
[TBL] [Abstract][Full Text] [Related]
29. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
[TBL] [Abstract][Full Text] [Related]
30. Enrichment of human marrow T-cell precursors by complement-dependent cytotoxicity with monoclonal antibodies and Percoll Gradient centrifugation.
Ahmad M; de Laforest PG; Janossy G; Tanzer J
Exp Hematol; 1987 Nov; 15(10):1035-40. PubMed ID: 3499336
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow T cell colony-forming cells: studies of their origin and use in monitoring T cell-depleted bone marrow grafts.
Knott LJ; Levinsky RJ; Newland AC; Jones HM; Linch DC
Clin Exp Immunol; 1985 Dec; 62(3):561-9. PubMed ID: 3910318
[TBL] [Abstract][Full Text] [Related]
32. Addition of a bone marrow "facilitating cell" population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma.
Yaroslavskiy B; Colson Y; Ildstad S; Parrish D; Boggs SS
Exp Hematol; 1998 Jul; 26(7):604-11. PubMed ID: 9657135
[TBL] [Abstract][Full Text] [Related]
33. The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease.
Jansen J; Goselink HM; Veenhof WF; Zwaan FE; Blotkamp C
Exp Hematol; 1983 Nov; 11(10):967-73. PubMed ID: 6363114
[TBL] [Abstract][Full Text] [Related]
34. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Soiffer RJ; Ritz J
Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
[TBL] [Abstract][Full Text] [Related]
35. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
36. T-cell depletion does not affect long-term human bone marrow culture.
Rio B; Bernier C; Andreu G; Perrot JY; Cadiou M; Bernard A; Zittoun R
Bone Marrow Transplant; 1987 Feb; 1(3):311-5. PubMed ID: 3509714
[TBL] [Abstract][Full Text] [Related]
37. AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies.
Perfetti V; Bellotti V; Garini P; Zorzoli I; Rovati B; Marinone MG; Ippoliti G; Merlini G
Lab Invest; 1994 Dec; 71(6):853-61. PubMed ID: 7807967
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
39. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
Uckun FM; Ramakrishnan S; Houston LL
J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
